These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2024719)

  • 1. Comparison of blood aldehyde dehydrogenase activities in moist snuff users, cigarette smokers and nontobacco users.
    Helander A; Curvall M
    Alcohol Clin Exp Res; 1991 Feb; 15(1):1-6. PubMed ID: 2024719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine intake and dependence in Swedish snuff takers.
    Holm H; Jarvis MJ; Russell MA; Feyerabend C
    Psychopharmacology (Berl); 1992; 108(4):507-11. PubMed ID: 1410167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagen levels in urine from snuff users, cigarette smokers and non tobacco users--a comparison.
    Curvall M; Romert L; Norlén E; Enzell CR
    Mutat Res; 1987 Jun; 188(2):105-10. PubMed ID: 3295535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
    Andersson G; Björnberg G; Curvall M
    J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys.
    Tomar SL; Alpert HR; Connolly GN
    Tob Control; 2010 Apr; 19(2):104-9. PubMed ID: 20008157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users.
    Bolinder G; de Faire U
    Am J Hypertens; 1998 Oct; 11(10):1153-63. PubMed ID: 9799031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary cotinine levels of smokeless tobacco (Maraş powder) users.
    Cok I; Oztürk R
    Hum Exp Toxicol; 2000 Nov; 19(11):650-5. PubMed ID: 11211244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine intake by snuff users.
    Russell MA; Jarvis MJ; Devitt G; Feyerabend C
    Br Med J (Clin Res Ed); 1981 Sep; 283(6295):814-7. PubMed ID: 6794710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users.
    Gritz ER; Baer-Weiss V; Benowitz NL; Van Vunakis H; Jarvik ME
    Clin Pharmacol Ther; 1981 Aug; 30(2):201-9. PubMed ID: 7195786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study.
    Eliasson M; Asplund K; Evrin PE; Lundblad D
    Atherosclerosis; 1995 Feb; 113(1):41-53. PubMed ID: 7755654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of moist snuff in humans.
    Fant RV; Henningfield JE; Nelson RA; Pickworth WB
    Tob Control; 1999; 8(4):387-92. PubMed ID: 10629244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smokeless tobacco or nicotine replacement therapy has no effect on serum immunoglobulin levels.
    Gyllén P; Andersson BA; Qvarfordt I
    Respir Med; 2004 Feb; 98(2):108-14. PubMed ID: 14971872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors in young snuff-users and cigarette smokers.
    Eliasson M; Lundblad D; Hägg E
    J Intern Med; 1991 Jul; 230(1):17-22. PubMed ID: 2066707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human blood aldehyde dehydrogenase activity by cigarette-smoke condensate.
    Helander A; Löwenmo C; Wikström T; Curvall M
    Life Sci; 1991; 49(25):1901-5. PubMed ID: 1745106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects.
    Berggren U; Eriksson M; Fahlke C; Blennow K; Balldin J
    Alcohol Alcohol; 2007; 42(3):267-71. PubMed ID: 17526638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Overview of knowledge of health effects of smokeless tobacco. Increased risk of cardiovascular diseases and mortality because of snuff].
    Bolinder G
    Lakartidningen; 1997 Oct; 94(42):3725-31. PubMed ID: 9411127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers.
    Prasad GL; Jones BA; Chen P; Gregg EO
    Clin Chem Lab Med; 2016 Apr; 54(4):633-42. PubMed ID: 26495926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Case to Include Brand of Moist Snuff in Health Surveys.
    Timberlake DS
    Nicotine Tob Res; 2016 Aug; 18(8):1786-90. PubMed ID: 27020059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smokeless tobacco (moist snuff) use and the risk of developing rheumatoid arthritis: results from a case-control study.
    Jiang X; Alfredsson L; Klareskog L; Bengtsson C
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1582-6. PubMed ID: 24719251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal snuff use and cotinine in late pregnancy-A validation study.
    Gunnerbeck A; Raaschou P; Cnattingius S; Edstedt Bonamy AK; Wickström R
    Acta Obstet Gynecol Scand; 2018 Nov; 97(11):1373-1380. PubMed ID: 29900536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.